Viewing Study NCT07266168


Ignite Creation Date: 2025-12-24 @ 5:34 PM
Ignite Modification Date: 2025-12-24 @ 5:34 PM
Study NCT ID: NCT07266168
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-05
First Post: 2024-12-22
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Efficacy and Safety of Ivarmacitinib in the Treatment of Patients With Polymyalgia Rheumatica
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 2025-200
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NETWORK View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER_GOV View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View